Reply  by Jabara, Refat et al.
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[issue Sirolimus Levels of Distal
essel, Stented Myocardium,
nd Distal Myocardium
ith great interest we read the article by Li et al. (1) regarding
asomotor functional responses of a conduit coronary artery distal
o sirolimus-eluting stents in a porcine model. The researchers
tated in the discussion, “. . .most of the drug taken up into cardiac
issue was transferred by direct contact with the arterial wall, which
ay have served as a reservoir for subsequent transfer via diffusion,
r the vasa vasorum” (1). However, we have previously reported
hat tissue sirolimus levels of proximal/distal vessel, stented myo-
ardium, and proximal/distal myocardium were much lower (less
han 2%) than the stented vessel area concentration (peaked at 1
ay after stent implantation [14.5  10.9 ng/ml]). Moreover,
irolimus was not detected in either the proximal or distal
yocardium at 30 days (2). Therefore, even low sirolimus concen-
rations with short duration may affect vasomotor function.
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eply
he observations of Dr. Kaneda and colleagues are clearly perti-
ent to the issues we raised in the Discussion section of our article
1). A common hypothesis generated by both of our results seems
o be whether long-term (1 month post-implantation of sirolimus-
luting stents [SES] and even later) vasomotor dysfunction might
e caused by a direct effect of the drug itself at very low
oncentration or secondary effects mediated through SES-
riggered cellular interactions (for example, chronic SES-induced
nflammation in the stented segment elaborating cytokines or
ther substances that impact endothelium-dependent relaxation).e suggest that the data currently available are inconclusive, uecause neither of these possibilities can yet be ruled out. Of
nterest however is that Jabs et al. (2) recently reported increased
uperoxide and p67(phox)/rac1 nicotinamide adenosine dinucle-
tide phosphate oxidase and reduced nitric oxide, along with
asomotor dysfunction, in the aortas of rats given a 1-week
ontinuous infusion of sirolimus. Their report did not include a
istological assessment, but the recruitment of inflammatory cells
ould seem to be a plausible potential mechanism underlying these
henomena.
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hat We Should Know About
ifurcation Disease
read with great interest the paper by Latib and Colombo (1).
his review discussed 6 major classifications of coronary bifurca-
ion lesions. However, it failed to include a recently published
omprehensive classification of bifurcation lesions that is simple,
ractical, and inclusive of other important features of coronary
ifurcation lesions that are not mentioned in other classifications
2). This classification is based on a system composed of a single
refix (B, for bifurcation lesion) to which up to 3 main suffixes are
dded, describing important anatomical features of a given bifur-
ation lesion. This classification addresses 3 important technical
eatures of bifurcation lesions: the proximal segment size, athero-
clerotic disease burden, and the bifurcation angle. It is known that
f the proximal segment is too small (small is defined as less than
wo-thirds of the sum of the diameters of both branch vessels
suffix S, for small]), the kissing stenting technique cannot be
tilized (3). The Medina classification does not include this
